anti-Hepatocellular Carcinoma antibody product blog
Tags: Antibody; Monoclonal Antibody; Hepatocellular Carcinoma; anti-Hepatocellular Carcinoma antibody;
The Hepatocellular Carcinoma n/a (Catalog #MBS592004) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The mAb anti-Human Hepatocellular Carcinoma reacts with Human. Others not testedThere were no detectable positive reactions with other human tumor cell lines and solid tumour specimens. Showed negative reaction to all normal human adult tissues and fetal tissues tested. and may cross-react with other species as described in the data sheet. MyBioSource\'s Hepatocellular Carcinoma can be used in a range of immunoassay formats including, but not limited to, Indirect Immunofluorescence assay. Researchers should empirically determine the suitability of the Hepatocellular Carcinoma n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal antibody to human hapatocellular carcinoma.
Hepatocellular carcinoma frequently occurs in individuals infected with hepatitis virus B and/or C, and in alcoholic persons with cirrhosis. In countries where hepatitis is not epidemic, hepatocellular carcinoma is mostly metastatic cancers developed elsewhere in the body. At early stage, the cancer can be curable by surgical removal of small tumour if liver is in good condition or by transplantation if liver�s function is damaged because of disease. The cancer responds poorly to treatment at advanced stage.
Target Protein: Human hepato-cellular carcinoma related protein
Immunogen: Human liver carcinoma cells
Myeloma: Sp2/0-Ag14
Light Chain: Kappa
Reconstitution: Double distilled water is recommended to adjust the final concentration to 1.00mg/mL. Research Area: Oncology. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Hepatocellular Carcinoma are readily searchable from our website. Different antibodies against the same target such as Hepatocellular Carcinoma may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.